Loading…
Loading…
Hercules Capital (HTGC) concluded the recent trading session at $17.39, signifying a -1.25% move from its prior day's close.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
A seven-holding portfolio promising $12,500 a month sounds straightforward until you examine whose money is actually funding some of those distributions, and why the highest-yielding positions have the weakest claim to keeping their promises.
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Hercules Adviser LLC (“Hercules Adviser”), its wholly-owned registered investment adviser, has surpassed $2.3 billion in investable capital. The mile.
Hercules Capital's 41.6% biotech and healthcare exposure should benefit from improving sector funding, IPO activity, and M&A exits. Higher interest rates would increase HTGC's net investment income and EPS under its disclosed rate-sensitivity assumptions. HTGC's internal management structure supports a low operating cost ratio and consistently superior ROAA and ROAE versus BDC peers.
Hercules Capital is rated a hold as valuation has rebounded to a 45% premium to book value. HTGC outperformed sector peers with stable NII per share and a 2.1% NAV increase quarter-over-quarter. Credit quality improved year-over-year, with a notable 600 bps rise in Grade 1-rated investments.
Hercules Capital remains a 'Strong Buy' for high-income and total return, supported by a robust venture-lending platform and efficient internal management. HTGC delivered record Q2 investment income of $149 million, with NII per share up 4.7% YoY and strong dividend coverage at 125%. Portfolio quality remains high, with minimal nonaccruals, improved average portfolio grade, and a conservative 20% loan-to-value ratio.
BlackRock Inc. purchased a new stake in shares of Hercules Capital, Inc. (NYSE: HTGC) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 924,105 shares of the financial services provider's stock, valued at approximately $14,573,000. BlackRock Inc. owned approximately 0.49% of Hercules